Epidemiological Profile, Gastrointestinal Toxicity, and Treatment of Pelvic Cancers in Patients Managed with Radiotherapy to the Abdominal Pelvic Area
Texto completo
Figure
Documento similar
It is thought that a defective or missing BRCA1 protein is unable to repair damaged DNA or fix mutations that occur in other genes, which is the main cause of its association
The aim of our study was to evaluate the association between excess weight and cancer immunotherapy outcome and toxicity in patients with advanced solid and hematological tumors
therapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal
The primary care physician plays a prominent role in detecting relapses and second neoplasms, dealing with late-onset effects of cancer treatment, managing comorbidity, psy-
Of special concern for this work are outbreaks formed by the benthic dinoflagellate Ostreopsis (Schmidt), including several species producers of palytoxin (PLTX)-like compounds,
In a population presenting with both early and late/very late stent thrombosis containing a high proportion of current generation DES and undergoing imaging in the acute setting
Circulating interleukin 6 and albumin, and infliximab levels are good predictors of recovering efficacy after dose escalation infliximab therapy in patients with loss of response
Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American Society of Clinical Oncol- ogy
